Lumea, a pioneer digital pathology company, will showcase its state-of-the-art solutions for prostate cancer at the upcoming 34th International Prostate Cancer Update in February. Event Details: The 34th International Prostate…
In the ever-evolving landscape of healthcare, breakthroughs in technology play a pivotal role in transforming patient outcomes. Lumea, a distinguished digital pathology company, is gearing up to showcase its cutting-edge…
Digital pathology is often publicized as being more efficient than traditional pathology, yet can that assertion survive scrutiny? It turns out that, as with many things, the answer is: maybe….
In our fifth Ask a Pathologist Podcast episode, we had the privilege of interviewing Dr. Hillel Kahane about his favorite game-changing tools for pathologists. From pre-analytical tools to digital pathology…
The cost of implementing digital pathology can vary widely depending on several factors, including the scale of the operation, the specific technology chosen, and the location and resources of the…
Lumea Inc., a leader in integrated digital pathology solutions, is thrilled to announce its strategic partnership with AIRA Matrix Private Limited, a leading technology company that provides diagnostic, prognostic, and…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
